C. Cimarelli et al. / Tetrahedron: Asymmetry 22 (2011) 591–596
595
J = 10.7, 7.3 Hz), 4.19 (dq, 1H, J = 10.7, 7.3 Hz), 5.44 (s, 1H), 7.07–
7.88 (m, 11H), 12.40 (br s, 1H); 13C NMR (100 MHz, CDCl3): d
14.1, 21.4, 55.2, 57.0, 61.9, 111.4, 119.9, 121.6, 122.7,126.4,
126.7, 127.7, 128.7, 128.8, 128.9, 130.5, 132.9, 142.6, 156.6,
171.2. Anal. Calcd for C22H23NO3 (349.42): C, 75.62; H, 6.63; N,
4.01. Found: C, 75.71; H, 6.49; N, 4.25.
11.17 (br s, 1H); 13C NMR (100 MHz, CDCl3): d 14.1, 23.3, 54.6,
54.8, 55.3, 55.8, 61.8, 90.9, 94.3, 126.7, 127.7, 127.8, 128.8, 142.9,
159.6, 160.0, 161.3, 172.2. Anal. Calcd for C20H25NO5 (359.42): C,
66.83; H, 7.01; N, 3.90. Found: C, 66.69; H, 6.81; N, 4.12.
4.2.5.1. (R)-Ethyl 2-((R)-1-phenylethylamino)-2-(2-hydroxy-4,6-
dimethoxyphenyl)acetate (R,R)-3e.
1H NMR (400 MHz,
4.2.2. (S)-Ethyl 2-((R)-1-phenylethylamino)-2-(2-
mercaptonaphthalen-1-yl)acetate (R,S)-3b
CDCl3): d 1.18 (t, 3H, J = 7.0 Hz), 1.48 (d, 3H, J = 6.6 Hz), 3.12 (br
s, 1H), 3.74 (s, 6H), 3.85 (q, 1H, J = 6.6 Hz), 4.10 (dq, 1H, J = 10.7,
6.8 Hz), 4.18 (dq, 1H, J = 10.7, 7.3 Hz), 5.03 (s, 1H), 5.95 (d, 1H,
J = 2.6 Hz), 6.01 (d, 1H, J = 2.6 Hz), 7.18–7.36 (m, 5H), 11.40 (br s,
1H); 13C NMR (100 MHz, CDCl3): d 14.2, 21.1, 55.0, 55.1, 55.4,
56.0, 61.8, 90.9, 94.6, 102.2, 126.8, 127.6, 128.6, 143.2, 159.0,
159.7, 161.3, 172.4.
½
a 2D0
ꢁ
¼ þ213:2 (c 2.1, CHCl3); IR (Nujol):
mmax 3345, 1732, 1495,
1181, 812, 737 cmꢀ1 1H NMR (400 MHz, CDCl3): d 1.21 (t, 3H,
;
J = 6.8 Hz), 1.41 (d, 3H, J = 6.8 Hz), 2.40 (br s, 1H), 4.14 (dq, 1H,
J = 10.7, 6.8 Hz), 4.21 (dq, 1H, J = 10.7, 6.8 Hz), 4.51 (q, 1H,
J = 6.8 Hz), 4.52 (s, 1H), 7.25–7.95 (m, 12H); 13C NMR (100 MHz,
CDCl3): d 14.2, 24.7, 53.8, 61.5, 67.9, 127.5, 127.7, 128.3, 128.4,
128.5, 128.6, 128.7, 129.5, 129.7, 129.8, 133.2, 134.6, 136.2,
143.6, 169.3. Anal. Calcd for C22H23NO2S (365.49): C, 72.30; H,
6.34; N, 3.83. Found: C, 72.46; H, 6.49; N, 3.98.
4.2.6. (S)-Ethyl 2-((R)-1-phenylethylamino)-2-(1,3-dihydro-5-
hydroxyisobenzofuran-6-yl)acetate (R,S)-3f
Oil; ½a 2D0
ꢁ
¼ þ133:3 (c 2.7, CHCl3); IR (Nujol): mmax 3319, 1728,
1213, 1119, 743, 698 cmꢀ1
;
1H NMR (400 MHz, CDCl3): d 1.14 (t,
4.2.2.1.
(R)-Ethyl
2-((R)-1-phenylethylamino)-2-(2-merca-
1H NMR (400 MHz,
3H, J = 7.3 Hz), 1.47 (d, 3H, J = 6.8 Hz), 2.90 (br s, 1H), 3.74 (q, 1H,
J = 6.8 Hz), 4.00 (s, 1H), 4.07 (dq, 1H, J = 10.7, 7.3 Hz), 4.13 (dq,
1H, J = 10.7, 7.3 Hz), 5.87–5.92 (m, 4H), 6.36 (s 1H), 6.44 (s, 1H),
7.15–7.21 (m, 5H), 12.35 (br s, 1H); 13C NMR (100 MHz, CDCl3): d
14.1, 23.6, 27.1, 54.8, 62.1, 99.4, 101.1, 109.7, 110.9, 126.6, 127.9
128.0, 129.2, 140.5, 142.3 148.5, 155.3, 171.4. Anal. Calcd for
ptonaphthalen-1-yl)acetate (R,R)-3b.
CDCl3): d 1.24 (t, 3H, J = 7.3 Hz), 1.39 (d, 3H, J = 6.6 Hz), 2.40 (br
s, 1H), 4.16–4.22 (m, 2H), 4.38 (q, 1H, J = 6.6 Hz), 4.93 (s, 1H),
7.25–7.95 (m, 12H);
4.2.3. (S)-Ethyl 2-((R)-1-phenylethylamino)-2-(1-
hydroxynaphthalen-2-yl)acetate (R,S)-3c
C20H23NO4 (341.40): C, 70.36; H, 6.79; N, 4.10. Found: C, 70.18;
H, 6.95; N, 3.92.
Crystals; mp 110–112 °C (CH2Cl2/hexane); ½a D20
¼ þ87:9 (c 1.3,
ꢁ
CHCl3); IR (Nujol): mmax 3315, 1729, 1623, 1198, 1106, 735,
4.2.6.1. (R)-Ethyl 2-((R)-1-phenylethylamino)-2-(1,3-dihydro-5-
700 cmꢀ1
;
1H NMR (400 MHz, CDCl3): d 1.10 (t, 3H, J = 7.3 Hz),
hydroxyisobenzofuran-6-yl)acetate (R,R)-3f.
(c 1.9, CHCl3); IR (Nujol): mmax 3322, 1726, 1210, 1123, 741,
694 cmꢀ1 1H NMR (400 MHz, CDCl3): d 1.27 (t, 3H, J = 7.2 Hz),
½
a 2D0
ꢁ
¼ þ14:4
1.52 (d, 3H, J = 6.8 Hz), 3.12 (br s, 1H), 3.78 (q, 1H, J = 6.8 Hz),
4.04 (dq, 1H, J = 10.7, 7.3 Hz), 4.13 (dq, 1H, J = 10.7, 7.3 Hz), 4.31
(s, 1H), 7.01–8.35 (m, 11H), 12.20 (br s, 1H); 13C NMR (100 MHz,
CDCl3): d 14.1, 23.6, 55.0, 62.1, 62.4, 112.2, 118.6, 122.6, 125.1,
125.6, 126.6, 126.7, 127.4, 128.0, 128.2, 129.2, 134.4, 142.6,
154.1, 171.6. Anal. Calcd for C22H23NO3 (349.42): C, 75.62; H,
6.63; N, 4.01. Found: C, 75.40; H, 6.45; N, 4.26.
;
1.48 (d, 3H, J = 6.6 Hz), 2.90 (br s, 1H), 3.83 (q, 1H, J = 6.6 Hz),
4.22 (dq, 1H, J = 10.7, 7.2 Hz), 4.29 (dq, 1H, J = 10.7, 7.2 Hz), 4.32
(s, 1H), 5.82–5.86 (m, 4H), 6.37 (s 2H), 7.10–7.40 (m, 5H), 10.35
(br s, 1H); 13C NMR (100 MHz, CDCl3): d 14.4, 22.6, 56.2, 62.0,
62.1, 99.6, 101.2, 107.8, 112.1, 127.1, 128.1, 128.9, 129.0, 140.6,
142.5, 148.4, 153.1, 171.7. Anal. Calcd for C20H23NO4 (341.40): C,
70.36; H, 6.79; N, 4.10. Found: C, 70.49; H, 7.02; N, 4.01.
4.2.3.1.
(R)-Ethyl
2-((R)-1-phenylethylamino)-2-(1-hydrox-
1H NMR (400 MHz,
ynaphthalen-2-yl)acetate (R,R)-3c.
CDCl3): d 1.26 (t, 3H, J = 7.3 Hz), 1.54 (d, 3H, J = 6.8 Hz), 3.15 (br
s, 1H), 3.93 (q, 1H, J = 6.8 Hz), 4.22 (dq, 1H, J = 10.7, 7.3 Hz), 4. 31
(dq, 1H, J = 10.7, 7.3 Hz), 4.62 (s, 1H), 6.95–8.29 (m, 11H), 12.10
(br s, 1H).
4.2.7. (S)-Ethyl 2-((R)-1-phenylethylamino)-2-(4-amino-2-
hydroxyphenyl)acetate (R,S)-3g
Oil: ½a 2D0
ꢁ
¼ þ132:7 (c 3.0, CHCl3); IR (Nujol): mmax 3273, 1733,
1243, 1121, 743, 697 cmꢀ1
;
1H NMR (400 MHz, CDCl3): d 1.12 (t,
3H, J = 6.4 Hz), 1.45 (d, 3H, J = 6.8 Hz), 3.02 (br s, 2H), 3.74 (q, 1H,
J = 6.8 Hz), 3.97–4.15 (m, 3H), 4.06 (s, 1H), 6.14 (dd, 1H, J = 8.1,
2.1 Hz), 6.20 (d, 1H, J = 2.1 Hz), 6.67 (d, 1H, J = 8.1 Hz), 7.14–7.40
(m, 6H); 13C NMR (100 MHz, CDCl3): d 14.2, 23.6, 54.7, 61.9, 62.0,
103.6, 106.8, 110.1, 126.7, 127.9, 129.1, 131.5, 142.9, 148.1,
159.0, 172.1. Anal. Calcd for C18H22N2O3 (314.38): C, 68.77; H,
7.05; N, 8.91. Found: C, 68.92; H, 7.22; N, 9.18.
4.2.4. (S)-Ethyl 2-((R)-1-phenylethylamino)-2-(1-hydroxy-4-
methoxynaphthalen-2-yl)acetate (R,S)-3d
Oil, ½a 2D0
ꢁ
¼ þ83:1 (c 2.7, CHCl3); IR (Nujol): mmax 3302, 1732,
1459, 1213, 731, 658 cmꢀ1
;
1H NMR (400 MHz, CDCl3): d 1.12 (t,
3H, J = 7.0 Hz), 1.52 (d, 3H, J = 6.8 Hz), 2.60 (br s, 1H), 3.80 (q, 1H,
J = 6.8 Hz), 3.92 (s, 3H), 4.07 (dq, 1H, J = 10.7, 7.0 Hz), 4.14 (dq,
1H, J = 10.7, 7.0 Hz), 4.26 (s, 1H), 6.37 (s, 1H), 7.18–8.33 (m, 9H),
11.60 (br s, 1H); 13C NMR (100 MHz, CDCl3): d 14.1, 23.7, 55.1,
56.1, 62.0, 62.8, 106.4, 111.1, 121.6, 122.4, 125.8, 126.1, 126.2,
126.3, 126.7, 127.9, 129.1, 142.8, 147.7, 148.3, 171.5. Anal. Calcd
for C23H25NO4 (379.45): C, 72.80; H, 6.64; N, 3.69. Found: C,
72.68; H, 6.41; N, 3.87.
4.2.8. (S)-Eethyl 2-((R)-2-hydroxy-1-phenylethylamino)-2-(2-
hydroxynaphthalen-1-yl)acetate (R,S)-3h
Oil: ½a 2D0
ꢁ
¼ ꢀ96:7 (c 2.1, CHCl3); IR (Nujol): mmax 3303, 1722,
1623, 1211, 743, 700 cmꢀ1
;
1H NMR (400 MHz, CDCl3): d 0.99 (td,
3H, J = 7.3, 1.7 Hz), 3.70 (t, 1H, J = 5.1 Hz), 3.80–3.89 (m, 2H), 4.00
(dqd, 1H, J = 10.7, 7.3, 1.7 Hz), 4.09 (dqd, 1H, J = 10.7, 7.3, 1.7 Hz),
4.55 (br s, 2H) 5.15 (s, 1H), 7.07–7.79 (m, 11H), 12.05 (br s, 1H);
13C NMR (100 MHz, CDCl3): d 14.0, 56.2, 61.4, 62.3, 65.8, 109.7,
118.4, 119.6, 121.7, 128.1, 128.4, 128.6, 128.8, 129.0, 129.1, 129.3,
131.2, 133.8, 156.4, 171.0. Anal. Calcd for C22H23NO4 (365.42): C,
72.31; H, 6.34; N, 3.83. Found: C, 72.51; H, 6.46; N, 4.02.
4.2.5. (S)-Ethyl 2-((R)-1-phenylethylamino)-2-(2-hydroxy-4,6-
dimethoxyphenyl)acetate (R,S)-3e
Oil; ½a 2D0
ꢁ
¼ þ70:6 (c 2.1, CHCl3); IR (Nujol): mmax 3318, 1721,
1413, 1193, 1106, 731, 650 cmꢀ1
;
1H NMR (400 MHz, CDCl3): d
1.10 (t, 3H, J = 6.8 Hz), 1.42 (d, 3H, J = 6.8 Hz), 3.02 (br s, 1H),
3.66 (s, 3H), 3.68 (q, 1H, J = 6.8 Hz), 3.78 (s, 3H), 4.05 (dq, 1H,
J = 10.7, 6.8 Hz), 4.09 (dq, 1H, J = 10.7, 6.8 Hz), 4.68 (s, 1H), 6.02
(d, 1H, J = 2.6 Hz), 6.09 (d, 1H, J = 2.6 Hz), 7.14–7.38 (m, 5H),
4.2.8.1. (R)-Ethyl 2-((R)-2-hydroxy-1-phenylethylamino)-2-
(2-hydroxynaphthalen-1-yl)acetate
(R,R)-3h.
1H
NMR